Friday, 23 October 2026 Newsarchy UK live index
Search LLM RSS
NewsarchyUKUK
Every UK story. Mapped, sourced, and explained where it matters.
BREAKING
News UK households urged to stockpile for 72 hours 02:42 Sport FIFA Announces US Host for First Women's Club World Cup in 2028 02:41 Transport Uzbekistan and EAEU outline steps to deepen trade, investment 01:38 Business Tesla FSD mode active in fatal I-80 pedestrian crash 01:37 Business Moderna and Merck mRNA melanoma vaccine cuts recurrence risk by 42 percent 01:06 Business NSW regional town house prices defy downturn despite capital city falls 00:08 News UK households urged to stockpile for 72 hours 02:42 Sport FIFA Announces US Host for First Women's Club World Cup in 2028 02:41 Transport Uzbekistan and EAEU outline steps to deepen trade, investment 01:38 Business Tesla FSD mode active in fatal I-80 pedestrian crash 01:37 Business Moderna and Merck mRNA melanoma vaccine cuts recurrence risk by 42 percent 01:06 Business NSW regional town house prices defy downturn despite capital city falls 00:08
Topic

cancer immunotherapy

Moderna and Merck mRNA melanoma vaccine cuts recurrence risk by 42 percent

Moderna and Merck mRNA melanoma vaccine cuts recurrence risk by 42 percent

A personalized mRNA cancer vaccine developed by Moderna and Merck significantly reduces melanoma recurrence risks, according to landmark Phase 3 clinical trial results.

Business ·23 Oct 2026, 01:06 ·Maeve Turner 3 min read